SECTOR GAMMA AS - Q4 2020 holdings

$525 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 25.0% .

 Value Shares↓ Weighting
GILD BuyGILEAD SCIENCES INC$48,830,000
+62.0%
838,140
+75.7%
9.29%
+35.4%
MRK BuyMERCK & CO INC$47,298,000
+45.0%
578,211
+47.0%
9.00%
+21.2%
INCY BuyINCYTE CORP$30,585,000
+19.6%
351,629
+23.4%
5.82%
+0.0%
BDX NewBECTON DICKINSON & CO$30,488,000121,845
+100.0%
5.80%
MDT SellMEDTRONIC PLC$27,823,000
-16.4%
237,523
-25.8%
5.30%
-30.1%
BSX BuyBOSTON SCIENTIFIC CORP$24,816,000
+17.0%
690,282
+24.4%
4.72%
-2.2%
ALXN SellALEXION PHARMACEUTICALS INC$23,096,000
-6.2%
147,827
-31.3%
4.40%
-21.5%
BMY SellBRISTOL-MYERS SQUIBB CO$22,414,000
-31.3%
361,343
-33.2%
4.26%
-42.6%
PFE NewPFIZER INC$21,838,000593,250
+100.0%
4.16%
PKI SellPERKINELMER INC$20,654,000
-18.8%
143,931
-29.0%
3.93%
-32.1%
IONS BuyIONIS PHARMACEUTICALS INC$18,149,000
+61.8%
320,992
+35.8%
3.45%
+35.3%
BRKR SellBRUKER CORP$17,726,000
+15.2%
327,477
-15.4%
3.37%
-3.7%
ABT SellABBOTT LABS$16,713,000
-9.8%
152,640
-10.3%
3.18%
-24.6%
CVS SellCVS HEALTH CORP$16,106,000
+9.5%
235,818
-6.3%
3.06%
-8.4%
BIIB SellBIOGEN INC$16,059,000
-15.9%
65,585
-2.6%
3.06%
-29.7%
CAH BuyCARDINAL HEALTH INC$15,578,000
+16.3%
290,850
+2.0%
2.96%
-2.8%
ANTM SellANTHEM INC$15,207,000
-16.5%
47,360
-30.1%
2.89%
-30.2%
LH BuyLABORATORY CORP AMER HLDGS$14,669,000
+29.3%
72,064
+19.6%
2.79%
+8.1%
NUVA SellNUVASIVE INC$14,384,000
+2.3%
255,360
-11.8%
2.74%
-14.5%
LIVN BuyLIVANOVA PLC$13,323,000
+105.6%
201,230
+40.4%
2.54%
+71.9%
BIO SellBIO RAD LABS INCcl a$12,485,000
-4.8%
21,417
-15.9%
2.38%
-20.4%
CNC NewCENTENE CORP DEL$11,647,000194,012
+100.0%
2.22%
ELAN BuyELANCO ANIMAL HEALTH INC$11,295,000
+102.1%
368,291
+84.0%
2.15%
+68.9%
HCA SellHCA HEALTHCARE INC$10,560,000
+28.4%
64,210
-2.6%
2.01%
+7.4%
PRGO SellPERRIGO CO PLC$7,509,000
-24.5%
167,922
-22.5%
1.43%
-36.9%
RIGL BuyRIGEL PHARMACEUTICALS INC$5,595,000
+70.7%
1,598,649
+17.1%
1.06%
+42.8%
JNJ SellJOHNSON & JOHNSON$5,508,000
-35.2%
35,000
-38.7%
1.05%
-45.8%
ALNY BuyALNYLAM PHARMACEUTICALS INC$3,849,000
+35.6%
29,615
+51.9%
0.73%
+13.3%
NVAX NewNOVAVAX INC$1,282,00011,500
+100.0%
0.24%
CLVS ExitCLOVIS ONCOLOGY INC$0-156,969
-100.0%
-0.21%
CERN ExitCERNER CORP$0-26,122
-100.0%
-0.43%
A ExitAGILENT TECHNOLOGIES INC$0-169,734
-100.0%
-3.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BOSTON SCIENTIFIC CORP40Q1 20239.9%
BIO RAD LABS INC40Q1 20234.7%
BRISTOL-MYERS SQUIBB CO38Q3 202311.9%
BAXTER INTL INC34Q3 202312.7%
CARDINAL HEALTH INC34Q3 20238.1%
PERKINELMER INC33Q2 20216.3%
BIOGEN INC30Q3 20237.6%
ELEVANCE HEALTH INC30Q3 20235.6%
GILEAD SCIENCES INC29Q3 202314.0%
TENET HEALTHCARE CORP28Q3 20234.3%

View SECTOR GAMMA AS's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-11-06
13F-HR2023-08-09
13F-HR2023-05-12
13F-HR/A2023-02-08
13F-HR2023-02-07
13F-HR2022-11-09
13F-HR2022-08-05
13F-HR2022-05-06
13F-HR2022-02-08

View SECTOR GAMMA AS's complete filings history.

Compare quarters

Export SECTOR GAMMA AS's holdings